Form 4: Longeveron Inc. Executive Nataliya Agafonova Reports Stock Transaction
SEC Form 4 Filing
Nataliya Agafonova, Chief Medical Officer of Longeveron Inc., reports disposition of shares to cover tax obligations related to vesting of restricted stock units.
Summary
- On April 1, 2025, Nataliya Agafonova, Chief Medical Officer of Longeveron Inc., disposed of 7,566 shares of Class A Common Stock to satisfy tax obligations.
- The shares were withheld at a price of $1.5 per share.
- Following the transaction, Agafonova directly owns 144,128 shares, which includes restricted stock units subject to future vesting.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard transaction related to executive compensation.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it's a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of stock transaction (disposal of shares). |
| 04/03/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Longeveron Inc., LGVN, Nataliya Agafonova, Chief Medical Officer, Stock Transaction, Beneficial Ownership, Restricted Stock Units, Tax Obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.